Respiratory News and Research

RSS

Scientists make breakthrough in developing Nipah virus vaccine for pigs

Scientists at The Pirbright Institute have taken a major step forward in tackling one of the world's most dangerous viruses, the Nipah virus, by evaluating vaccine candidates for pigs.

23 Jul 2025

Global experts release guidance on CT imaging for post-COVID lung abnormalities

Experts representing multiple societies and institutions across 14 countries have published guidance for computed tomography (CT) imaging in patients with residual lung abnormalities after COVID-19 illness.

22 Jul 2025

Cleaner air after industrial plant closure improves lung health in local residents

A new study by NYU Langone Health researchers found that the shutdown of a significant fossil fuel pollution source near Pittsburgh, PA, resulted in immediate improvements in respiratory health.

22 Jul 2025

Can probiotics boost athletic performance? Review reveals what works and what still needs proof

A new review in Frontiers in Nutrition synthesizes recent evidence on how probiotic supplementation may impact gut health, immunity, and performance in athletes across various sports.

22 Jul 2025

AI reshapes ARDS care by predicting risk, guiding ventilation, and personalizing treatment

Artificial intelligence and machine learning are transforming acute respiratory distress syndrome (ARDS) management, enabling earlier detection, precision risk stratification, and tailored therapies. Emerging AI techniques promise to improve outcomes, but real-world clinical validation and integration remain critical challenges.

21 Jul 2025

Agricultural dust exposure may pose significant risks to gut health

Inhaling agricultural dust may pose significant risks to gut health for workers in animal agriculture, a University of California, Riverside, study has found.

18 Jul 2025

Maternal RSV vaccination linked to sharp drop in infant lung infections

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests.

18 Jul 2025

Home rehab program improves lung function in bronchiectasis

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis patients, reducing acute exacerbations.

18 Jul 2025

Parental cholesterol predicts asthma severity in children

Parental metabolic health influences childhood asthma severity, with paternal cholesterol showing modest protective effects against exacerbating symptoms.

18 Jul 2025

Discovery of hybrid Aspergillus species with antifungal resistance in Japan

Aspergillus is a fungus that is commonly found in the environment, both indoors and outdoors. This fungus species can cause aspergillosis-a respiratory infection affecting the lungs. A. fumigatus, A. nidulans, and A. niger are some of the common species within the Aspergillus genus that cause aspergillosis.

17 Jul 2025

endTB-Q trial highlights importance of individualized regimens

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs while others may warrant more aggressive therapy, according to the findings of a new study led by an international group of researchers including scientists from Harvard Medical School and conducted across six countries in Asia, Africa, and South America.

17 Jul 2025

New micro physiological system emulates different regions of the human lung

Respiratory infections such as COVID-19 have been responsible for numerous pandemics and have placed a substantial burden on healthcare systems.

16 Jul 2025

FINRISK population-based study investigates factors associated with prevalence of antibiotic resistance

A population-based study led by the University of Turku, Finland, investigated factors associated with the prevalence of antibiotic resistance.

16 Jul 2025

Routine vaccines may be the key to fighting antibiotic resistance

A study reveals that rising vaccine coverage in children is linked to reduced antibiotic prescriptions, suggesting a shift in the fight against drug resistance.

16 Jul 2025

Qureight analyze of Insilico Medicine's Phase IIa rentosertib data support preliminary efficacy results and future trial expansion

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a collaboration with Insilico Medicine ("Insilico"), a clinical-stage biotechnology company driven by generative AI, focused on rentosertib (ISM001-055), a novel TNIK inhibitor discovered using Insilico's generative AI approach, in development for the treatment of IPF.

16 Jul 2025